Kangwei Century Secures Medical Device Registration for Multiplex Respiratory Pathogen Detection Kit

Stock News
Mar 04

Jiangsu Cowin Biotech Co., Ltd. (688426.SH) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostics Technology Co., Ltd., has received a Class III Medical Device Registration Certificate for In Vitro Diagnostic Reagents from the National Medical Products Administration for its self-developed Nine Respiratory Pathogen Nucleic Acid Detection Kit (Fluorescent PCR Method). According to the announcement, this product utilizes fluorescent quantitative PCR technology and advanced freeze-drying methods to qualitatively detect nucleic acids from nine pathogens in human throat swab samples. The pathogens detected include Influenza A virus, Influenza B virus, Respiratory Syncytial Virus, Human Rhinovirus, Mycoplasma pneumoniae, Adenovirus, Parainfluenza Virus Type I, Parainfluenza Virus Type II, and Parainfluenza Virus Type III.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10